about
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adultsIntermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adultsHuman dendritic cells in allergic asthma and rhinitisInhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease.Eosinophil survival and apoptosis in health and disease.Advances in the immunobiology of eosinophils and their role in disease.Outcome of occupational asthma after removal from exposure: A follow-up study.Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid.Omalizumab, a novel anti-IgE therapy in allergic disorders.Inhaled corticosteroids and the risk of diabetes among the elderlyCurrent recommendations for the treatment of mild asthma.Fluticasone propionate in asthma: a long term dose comparison study.Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.An update of the leukotriene modulators for the treatment of asthma.Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling.Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialFluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study).Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.Early intervention for infantile and childhood asthma.Epithelial function and dysfunction in asthma.Dendritic cells revisited in human allergic rhinitis and asthma.Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.Asthma and Chronic Obstructive Pulmonary Disease (COPD) - Differences and Similarities.Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle.Protective effects of Scrophularia striata in Ovalbumin-induced mice asthma modelThe cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone.Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma.Dating relationships in college students with childhood-onset asthma.Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre.Assessment of biological, psychological and adherence factors in the prediction of step-down treatment for patients with well-controlled asthma.Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
P2860
Q24186347-C152E615-171D-43A0-9890-F28CC5F782C7Q24197698-A89172EF-9FF8-421F-9090-8387708D194DQ28080738-FCC8E7C2-D09D-49E4-B22B-7701C18902AAQ33737170-50DAB62B-E39B-4B59-AD21-0510305753C7Q33758139-D4440318-925A-4429-A280-500D6BB45292Q33773048-DA8C8477-0B0D-43E5-9DCF-D11CB3784C38Q33836175-C2741DD7-322E-4574-A6BC-4671B309F30BQ34086906-45780B1F-6076-4BD6-917C-ABE912F3F0A3Q34452726-A66FA5F8-8E36-47E9-B8C6-A9C5BEBBD357Q34524994-C8B15E15-C424-40C5-8B6E-AA13DF3C2D63Q34620134-0E207E75-FB9C-4A3C-ACCE-B861B2BFF887Q35571425-7D55B138-3DA5-4FC9-8110-9B09994C8D22Q35653704-5B75CA07-C95B-4416-9963-C5D8E6C4327AQ35814442-F1A54D18-C948-459C-909C-58EEFFF47270Q36023612-5A48628D-6E09-40FC-B2EC-48DA723E8361Q36316793-8CA1A57F-8717-4368-A8A0-2D28D82667A3Q36351758-F18ACA70-0B71-42E5-9D77-AD471F25E6C2Q36750899-C588DF8A-157A-4800-9779-3AD63C47D362Q36869140-A3F585E0-AC67-4FCA-8AC8-9DA475DEB339Q36874335-75C9CF79-3B02-4141-B3ED-AA26A563D99DQ37733515-9FF2A1BA-149B-4A3A-9623-BA838BBB86DCQ38198788-BB3A7CDB-60EB-4C7F-A483-66C1D1994298Q38596794-B3D54993-147F-4E25-96C2-736E6727D1E3Q38896504-2EC08313-EA5B-4CAF-9D2A-6EA7923CEABBQ39135769-924B2D24-AD44-42A9-9CB8-32870F61C6A8Q39670594-57F0B046-8B1E-45BA-8576-2968FC285E20Q41861629-4B6D6148-59EB-4528-9C6F-D032E484DE0EQ42114151-4F731A80-7473-4264-A519-1068CC805430Q43819597-CC316C39-FB12-4FD2-B7CC-B3B18702E416Q44110885-B98F06A2-5401-4CD7-9941-900621AB4A32Q44803823-3DE715D6-CE00-46F9-98C3-5957A485FD3FQ47265923-147EFB99-9610-437F-A902-EAB8D1C29C7CQ47301858-52CB5545-FB94-4C11-A4C2-F476F9EBEB18Q47772446-62A3963B-CD2D-4B85-BAAF-4B6F803EA6E2Q50524228-94EFC71C-2CF5-441C-97DC-1AF929032CF0
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Efficacy of inhaled corticosteroids in asthma.
@en
type
label
Efficacy of inhaled corticosteroids in asthma.
@en
prefLabel
Efficacy of inhaled corticosteroids in asthma.
@en
P1476
Efficacy of inhaled corticosteroids in asthma.
@en
P2093
P304
P356
10.1016/S0091-6749(98)70268-4
P407
P433
P577
1998-10-01T00:00:00Z